Brief resolved unexplained event

From WikiMD's WELLNESSPEDIA


Brief resolved unexplained event
Synonyms BRUE, Apparent life-threatening event (ALTE)
Pronounce N/A
Specialty N/A
Symptoms Apnea, cyanosis, muscle tone changes, altered level of consciousness
Complications N/A
Onset Typically in infants <1 year old
Duration Less than 1 minute
Types N/A
Causes Unknown, but may include gastroesophageal reflux disease, seizures, respiratory infections
Risks Premature birth, history of similar events
Diagnosis Clinical evaluation, exclusion of other causes
Differential diagnosis Seizure disorder, gastroesophageal reflux disease, respiratory infection, child abuse
Prevention N/A
Treatment Observation, reassurance, addressing underlying causes if identified
Medication N/A
Prognosis Generally good, low risk of recurrence
Frequency Common in infants, exact prevalence unknown
Deaths N/A


Brief Resolved Unexplained Event (BRUE) is a term used in pediatric medicine to describe an incident occurring in an infant that is alarming to the observer, but where the cause of the event remains unclear even after a thorough investigation. These events were previously known as Apparent Life-Threatening Events (ALTE), but the terminology was updated to BRUE by the American Academy of Pediatrics in 2016 to more accurately describe these incidents without implying a life-threatening prognosis.

Definition[edit]

A BRUE is diagnosed when an infant younger than one year experiences an episode that is sudden, brief (less than one minute), and now resolved, with the event having at least one of the following characteristics:

  • Cyanosis or pallor
  • Absent, decreased, or irregular breathing
  • Marked change in tone (hypertonia or hypotonia)
  • Altered level of responsiveness

The event must be unexplained after conducting an appropriate history and physical examination, meaning that there is no identifiable medical condition that explains the episode.

Classification[edit]

BRUEs are classified into two categories based on risk: low-risk and high-risk. This classification helps guide further evaluation and management.

  • Low-risk BRUE: This category includes infants who are older than 60 days, born after 32 weeks gestation and corrected for prematurity, have no history of similar events, and who exhibit no concerning features during history taking and physical examination.
  • High-risk BRUE: Infants not meeting the criteria for low-risk BRUE are considered high-risk. These infants may require more extensive evaluation and monitoring.

Evaluation[edit]

The evaluation of an infant after a BRUE may include, but is not limited to:

  • Detailed medical history, including prenatal, birth, and family history
  • Physical examination focusing on neurological and respiratory systems
  • Appropriate laboratory tests and imaging studies based on clinical judgment

Management[edit]

Management strategies for BRUE are tailored based on the risk assessment:

  • Low-risk BRUE: Infants can often be managed with careful observation and possibly brief hospitalization. Parental education on safe infant care practices and the benign nature of most BRUEs is crucial.
  • High-risk BRUE: These infants may require hospitalization for monitoring, further diagnostic evaluation, and possibly treatment for any underlying conditions identified.

Prognosis[edit]

The prognosis for infants who experience a BRUE is generally good, especially for those classified as low-risk. However, the underlying cause of the event, if identified, may influence the long-term outlook.

Prevention[edit]

Preventive measures for BRUE are not well-defined due to the unexplained nature of these events. However, following safe sleep guidelines and ensuring a smoke-free environment for the infant are recommended.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.